1. Home
  2. NTZ vs MURA Comparison

NTZ vs MURA Comparison

Compare NTZ & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTZ
  • MURA
  • Stock Information
  • Founded
  • NTZ 1959
  • MURA 2013
  • Country
  • NTZ Italy
  • MURA Ireland
  • Employees
  • NTZ N/A
  • MURA N/A
  • Industry
  • NTZ Home Furnishings
  • MURA
  • Sector
  • NTZ Consumer Discretionary
  • MURA
  • Exchange
  • NTZ Nasdaq
  • MURA Nasdaq
  • Market Cap
  • NTZ 31.2M
  • MURA 35.7M
  • IPO Year
  • NTZ 1993
  • MURA N/A
  • Fundamental
  • Price
  • NTZ $3.68
  • MURA $2.08
  • Analyst Decision
  • NTZ
  • MURA Strong Buy
  • Analyst Count
  • NTZ 0
  • MURA 3
  • Target Price
  • NTZ N/A
  • MURA $12.00
  • AVG Volume (30 Days)
  • NTZ 3.5K
  • MURA 467.9K
  • Earning Date
  • NTZ 10-21-2025
  • MURA 11-12-2025
  • Dividend Yield
  • NTZ N/A
  • MURA N/A
  • EPS Growth
  • NTZ N/A
  • MURA N/A
  • EPS
  • NTZ N/A
  • MURA N/A
  • Revenue
  • NTZ $337,653,480.00
  • MURA N/A
  • Revenue This Year
  • NTZ N/A
  • MURA N/A
  • Revenue Next Year
  • NTZ N/A
  • MURA N/A
  • P/E Ratio
  • NTZ N/A
  • MURA N/A
  • Revenue Growth
  • NTZ N/A
  • MURA N/A
  • 52 Week Low
  • NTZ $2.15
  • MURA $0.95
  • 52 Week High
  • NTZ $6.27
  • MURA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • NTZ 62.35
  • MURA 52.01
  • Support Level
  • NTZ $2.94
  • MURA $2.05
  • Resistance Level
  • NTZ $3.50
  • MURA $2.09
  • Average True Range (ATR)
  • NTZ 0.15
  • MURA 0.01
  • MACD
  • NTZ 0.06
  • MURA 0.01
  • Stochastic Oscillator
  • NTZ 70.54
  • MURA 50.00

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: